Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet

Journal of Bioscience and Bioengineering

Volumn 118, Issue 4, 2014, Pages 476-481

  Gao, Xiang ^a   Liu, Xiaofang ^a   Xu, Jie ^a   Xue, Changhu ^a   Xue, Yong ^a   Wang, Yuming ^a  

^a OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Glucose tolerance; High fat diet; Inflammation; Insulin resistance; Trimethylamine N oxide

Indexed keywords

GENE EXPRESSION; INSULIN; MAMMALS; MEDICAL PROBLEMS; NUTRITION; PATHOLOGY; TISSUE;

GLUCOSE TOLERANCE; HIGH-FAT DIET; INFLAMMATION; INSULIN RESISTANCE; TRIMETHYLAMINE N OXIDES;

GLUCOSE;

GLUCOSE; GLYCOGEN; INSULIN; INTERLEUKIN 10; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIMETHYLAMINE OXIDE; CCL2 PROTEIN, MOUSE; FAT INTAKE; GLUCOSE BLOOD LEVEL; IL10 PROTEIN, MOUSE; METHYLAMINE; TRIMETHYLOXAMINE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DISEASE EXACERBATION; GENE EXPRESSION; GENERAL PATHOLOGICAL PARAMETERS; GENETIC ASSOCIATION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HOMEOSTASIS MODEL ASSESSMENT ESTIMATED INSULIN RESISTANCE; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; SIGNAL TRANSDUCTION; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; FAT INTAKE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; LIVER; METABOLISM; PATHOLOGY;

MUS;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CHEMOKINE CCL2; DIET, HIGH-FAT; DIETARY FATS; FASTING; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-10; LIVER; MALE; METHYLAMINES; MICE; MICE, INBRED C57BL;

EID: 84921636319     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2014.03.001     Document Type: Article

References (43)

1. Klein M.S., Dorn C., Saugspier M., Hellerbrand C., Oefner P.J., Gronwald W. Discrimination of steatosis and NASH in mice using nuclear magnetic resonance spectroscopy. Metabolomics 2011, 7:237-246.
2. Duggan G.E., Hittel D.S., Sensen C.W., Weljie A.M., Vogel H.J., Shearer J. Metabolomic response to exercise training in lean and diet-induced obese mice. J.Appl. Physiol. 2011, 110:1311-1318.
3. Shearer J., Duggan G., Weljie A., Hittel D.S., Wasserman D.H., Vogel H.J. Metabolomic profiling of dietary-induced insulin resistance in the high fat-fed C57BL/6J mouse. Diabetes Obes. Metab. 2008, 10:950-958.
4. Schirra H.J., Anderson C.G., Wilson W.J., Kerr L., Craik D.J., Waters M.J., Lichanska A.M. Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study. PLoS One 2008, 3:2764.
5. Dumas M.E., Barton R.H., Toye A., Cloarec O., Blancher C., Rothwell A., Fearnside J., Tatoud R., Blanc V., Lindon J.C., other 13 authors Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. USA 2006, 103:12511-12516.
6. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S., DuGar B., Feldstein A.E., Britt E.B., Fu X., Chung Y.M. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63.
7. Dyer W.J. Amines in fish muscle. VI. Trimethylamine oxide content of fish and marine invertebrates. J.Fish. Res. Board Can. 1952, 8:314-324.
8. Kelly R.H., Yancey P.H. High contents of trimethylamine oxide correlating with depth in deep-sea teleost fishes, skates, and decapod crustaceans. Biol. Bull. 1999, 196:18-25.
9. Li X., Chen Y., Liu J., Yang G., Zhao J., Liao G., Shi M., Yuan Y., He S., Lu Y. Serum metabolic variables associated with impaired glucose tolerance induced by high-fat-high-cholesterol diet in Macaca mulatta. Exp. Biol. Med. 2012, 237:1310-1321.
10. Kahn B.B., Flier J.S. Obesity and insulin resistance. J.Clin. Invest. 2000, 106:473-481.
11. Lee Y.S., Cha B.Y., Choi S.S., Choi B.K., Yonezawa T., Teruya T., Nagai K., Woo J.T. Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice. J.Nutr. Biochem. 2013, 24:156-162.
12. DeBoer M.D. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition 2013, 29:379-386.
13. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
14. Lagathu C., Bastard J.P., Auclair M., Maachi M., Capeau J., Caron M. Chronic interleukin-6(IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem. Biophys. Res. Commun. 2003, 311:372-379.
15. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J.Clin. Invest. 2006, 116:1494-1505.
16. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J.Clin. Invest. 2006, 116:1793-1801.
17. Folch J., Lees M., Sloane Stanley G.H. Asimple method for the isolation and purification of total lipides from animal tissues. J.Biol. Chem. 1957, 226:497-509.
18. Plum A.S., Jonathan D.S., Tony H. Severe hypereholesterolemia and atherosclerosis in apolipoprotein E deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
19. Bartlett G.R. Phosphorous assay in column chromatography. J.Biol. Chem. 1959, 234:466-468.
20. Xia Z., Sniderman A.D., Cianflone K. Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J.Biol. Chem. 2002, 277:45874-45879.
21. Haluzik M.M., Lacinova Z., Dolinkova M., Haluikova D., Housa D., Horinek A., Vernerova Z., Kumstyrova T., Haluzik M. Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels. Endocrinology 2006, 147:4517-4524.
22. Haffner S.M., Gonzalez C., Miettinen H., Kennedy E., Stern M.P. Aprospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care 1996, 19:1138-1141.
23. Eschwege E. The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications. Diabetes Metab. 2003, 6:19-27.
24. Mokdad A.H., Bowman B.A., Ford E.S., Vinicor F., Marks J.S., Koplan J.P. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001, 286:1195-2000.
25. Raghavan V.A. Insulin resistance and atherosclerosis. Heart Fail. Clin. 2012, 8:575-587.
26. Han J.W., Zhan X.R., Li X.Y., Xia B., Wang Y.Y., Zhang J., Li B.X. Impaired PI3K/Akt signal pathway and hepatocellular injury in high-fat fed rats. World. J. Gastroenterol. 2010, 16:6111-6118.
27. Farrar C., Houser C.R., Clarke S. Activation of the PI3K/Akt signal transduction pathway and increased levels of insulin receptor in protein repair-deficient mice. Aging Cell 2004, 4:1-12.
28. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1α interaction. Nature 2003, 423:550-555.
29. Stolarczyk E., Le Gall M., Even P., Houllier A., Serradas P., Brot-Laroche E., Leturque A. Loss of sugar detection by GLUT2 affects glucose homeostasis in mice. PLoS One 2007, 2:1228.
30. Fang X., Gao G., Xue H., Zhang X., Wang H. Exposure of perfluorononanoic acid suppresses the hepatic insulin signal pathway and increases serum glucose in rats. Toxicology 2012, 294:109-115.
31. Vidal-Vanaclocha F. Inflammation in the molecular pathogenesis of cancer and atherosclerosis. Reumatol. Clin. 2009, 5:40-43.
32. Paccaud F., Schlüter-Fasmeyer V., Wietlisbach V., Bovet P. Dyslipidemia and abdominal obesity: an assessment in three general populations. J.Clin. Epidemiol. 2000, 53:393-400.
33. Miri R., Saadati H., Ardi P., Firuzi O. Alterations in oxidative stress biomarkers associated with mild hyperlipidemia and smoking. Food Chem. Toxicol. 2012, 50:920-926.
34. Orsó E., Ahrens N., Kilalić D., Schmitz G. Familial hypercholesterolemia and lipoprotein(a) hyperlipidemia as independent and combined cardiovascular risk factors. Atheroscler. Suppl. 2009, 10:74-78.
35. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J.Clin. Invest. 2003, 112:1821-1830.
36. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J.Clin. Invest. 2003, 112:1796-1808.
37. Yu R., Kim C.S., Kwon B.S., Kawada T. Mesenteric adipose tissue-derived monocyte chemoattractant protein-1 plays a crucial role in adipose tissue macrophage migration and activation in obese mice. Obesity 2006, 14:1353-1362.
38. Sartipy P., Loskutoff D.J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 2003, 100:7265-7270.
39. Moore K.W., Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
40. Straczkowski M., Kowalska I., Nikolajuk A., Krukowska A., Gorska M. Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals. Diabetes Care 2005, 28:2036-2037.
41. Kim H.J., Higashimori T., Park S.Y., Choi H., Dong J., Kim Y.J. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 2004, 53:1060-1067.
42. Fasching P., Ratheiser K., Waldhäusl W., Rohac M., Osterrode W., Nowotny P., Vierhapper H. Metabolic effec4ts of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 1991, 40:583-589.
43. Samane S., Christon R., Dombrowski L., Turcotte S., Charrouf Z., Lavigne C., Levy E., Bachelard H., Amarouch H., Marette A. Fish oil and argan oil intake differently modulate insulin resistance and glucose intolerance in a rat model of dietary-induced obesity. Metabolism 2009, 58:909-919.